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We report a case of RCZ caused by Rhizopus arrhizus 
(oryzae in an 84-year-old woman with poorly controlled 
diabetes. She presented with a right-sided facial droop 
of short origin, being generally unwell and ‘off legs’ over 
2 weeks with reduced appetite. Initial non-conclusive CT 
scans and late in disease appearance of key markers 
of RCZ were probably factors permitting mycosis to 
rapidly progress in its course. Despite an intensive anti- 
fungal therapy with AmBisome and Insulin sliding scale, 
patient rapidly succumbed within 4 days of presenting. 
Fine needle aspiration cytology has been suggested 
as a possible, less invasive, easier and equally effective 
alternative to pre op biopsy. The key to successful 
reduction in morbidity and mortality associated with 
this rapidly fatal disease is increasing awareness of the 
disease, an early diagnosis, correction of underlying 
metabolic derangement, prompt intensive antifungal 
therapy with amphotericin B and radical surgical 
debridement of the necrotic tissue. 
Successful treatment of fungal meningitis and 
arachnoiditis with IV voriconazole in chronic 
gramdomatous disease (CGD) 
Kiran Belani, Park Nicollet Clinic, Minneapolis, MN; 
William Mize, Childrens Hospitals and Clinic, 
Department of Radiology, Minneapolis, MN, and 
Thomas Walsh, National Cancer Institute Bethesda, 
MD, USA 
Four year old black male with chronic granulomatous 
disease (CGD) diagnosed at 3 years and on treatment 
with Gamma Interferon and TMP/SMX presents with 
chronic bilateral pneumonia unresponsive to antibiotics. 
Bilateral lobectomy is done for Aspergillus fumigatus 
pneumonia and Rx with IV amphotericin for 4 months. 
Persistent headache lead to diagnosis of intracerebral 
hemorrhage requiring craniotomy and resection of R 
frontal mycotic aneurysm negative on fungal culture. On 
continued amphotericin therapy, 4 weeks later has 
intermittent sharp shooting pain in lower extremity and 
meningismus. Lumbar puncture reveals cerebrospinal 
fluid (CSF) polymorphonuclear pleocytosis, low glucose, 
elevated protein and negative fungal, bacterial and viral 
cultures. MRI spine has abnormal enhancement along 
the entire spinal cord and increased intensity in patchy 
areas in the conus medullaris and mid thoracic region. 
MRI brain shows meningeal enhancement and ventri- 
cular enlargement. Multiple craniotomy procedures were 
done to decompress the ventricles with ventriculostomy, 
Rickham reservoir and finally a ventriculoperitoneal 
shunt. Laminectomy and biopsy of spinal cord patchy 
lesions show inflammation with branching hyphae and 
yeast forms with negative cultures of tissue obtained. 
PCR was done. One CSF sample was positive for 
Trichosporon beiglii with multiple negative cultures. 
Steroid Rx started for increasing intracranial pressure 
(ICP), seizures and CSF protein on amphotericin and 
itraconazole Rx. Due to lack of clinical response anti- 
fungal Rx was changed to voriconazole (3mg/kg/dose 
BID X 12 weeks IV) provided by Pfizer (compassionate 
protocol). Patient is on oral voriconazole maintainence 
Rx for past 15 months with no steroids. He is seizure 
free, has a normal neurological examination with no 
adverse events during voriconazole therapy. Follow up 
MRI spine at 18 months shows no new areas of patchy 
lesion with resolution of previous abnormalities except 
for residual scarring. Serial MRI pictures during disease 
process will be displayed. 
A functional analysis of the Al&, Als6 and 
AM genes of Candida albicans 
D. C. Sheppard, A. S. Ibrahim, Y Fu, S. G. Filler, 
J. E. Edwards Jr. 
Division of Infectious Diseases, Harbor- UCLA 
Research and Education Institute, Torrance, CA, USA 
Background: Adherence of Candida albicans to host 
constituents, including endothelial cells and the base- 
ment membrane, is a critical early step in the patho- 
genesis of disseminated candidiasis. Recently, members 
of the C. albicans ALS (Aglutinin-Like-Sequence) 
gene family have been implicated as candidal adhesins. 
When the C. albicans ALS.5 gene is expressed in the 
normally non-adherent Saccharomyces cerevisiae, it 
renders this organism adherent to host constituents such 
as fibronectin. Two other members of the ALS gene 
family (ALS6 and ALS7) share considerable homology 
with AL%, but their function remains unknown. 
Purpose: To clone the C. albicans ALS6 and ALS7 gene 
and determine the role of their gene products in both 
adherence to host constituents and virulence in the 
mouse model of disseminated candidiasis. 
Methods: The coding sequence of ALSS, ALS6 and 
ALS7 were cloned using high fidelity PCR, placed under 
the control of the constitutive ADHl promotor and 
expressed in S. cerevisiae. Adherence of these strains to 
fibronectin was then tested using a magnetic bead assay. 
Using a PCR based disruption strategy, homozygous C. 
albicans null mutants of AL,!% and ALS7 were 
constructed, and the virulence of these strains was tested 
in the mouse model of disseminated candidiasis. 
Results: In contrast to AL%, heterologous expression 
of ALS6 and ALS7 in S. cerevisiae did not enhance 
adherence to fibronectin-coated beads. To further 
localize the area responsible for mediating binding to 
fibronectin, we constructed chimeric genes consisting of 
the N-terminal region of ALSS fused to the C-terminus 
of ALS6 (5N6C) and the ALS6 N-terminus fused to the 
ALSS C-terminus (6N5C). Expression of these con- 
structs in S cerevisiae resulted in enhanced adherence 
to fibronectin only in the strain expressing 5N6C. 
Consistent with these results, C. albicans ALS6 and 
ALS7 null mutants demonstrated normal virulence in 
the mouse model of disseminated candidiasis. 
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Conclusions: Despite the high degree of sequence 
homology to ALS.5, the ALS6 and ALS7 genes of C. 
albicans do not mediate adherence to fibronectin. These 
functional differences despite sequence homology have 
allowed us to produce chimeric ALS genes, and thereby 
localize the fibronectin-binding domain of ALS.5 to the 
N-terminal portion of the gene product. This technique 
will be invaluable in further defining the key binding 
domain of the Als5 protein, a critical initial step in the 
development of novel therapeutics targeted at the 
inhibition of candidal adherence. 
A case report of Geotrichum infection in a patient 
with CLL 
H. L. Durham, S. A. Kemmerly, J. B. Garcia-Diaz, 
K. L. Baumgarten, J. R. Dalovisio, A. K. Ramjiani, 
M. Billeter, G. A. Pankey 
Ochsner Clinic Foundation;* New Orleans, LA, USA 
Geotrichum is a ubiquitous fungus distinctive for 
arthrocondia and septated hyphae. It is present in soil, 
fruits and dairy products and is a markedly rare human 
systemic pathogen with a reported mortality rate of 
70-75 %. We present a neutropenic 64-year male patient 
with CLL treated since mid 2001 with fludarabine based 
chemotherapy and prophylactic tmp/smz who was re- 
admitted for fungemia in February 2002. 
The patient’s complex illness included four cycles of 
chemotherapy, and hospitalizations the prior September 
and December for neutropenic fever with an absolute 
neutrophil count (ANC) less than 200 on both admissions. 
During the December admission a biopsy of a left thigh 
lesion grew Nocardia brusiliensis that was treated with 
appropriate intravenous and then outpatient oral 
therapy. In January 2002, complaining on this occasion 
of right lower leg swelling and pain, the patient was 
readmitted with an ANC of zero. Chemotherapeutic 
coverage for Nocardia was in-tensified and robust anti- 
biotic management for neutropenia administered. After 
more than a fortnight of inpatient management, the 
patient was afebrile and was discharged on outpatient 
antibiotics. Within two days of discharge, the lab reported 
fungemia. 
On prompt readmission intensive antibacterial and 
antifungal therapy was given. One-day post admission 
the blood culture isolate was identified as Geotrichum. 
Imaging revealed multiple lesions in the soft tissues and 
musculature of both 1egs.A cystic area of the right lower 
leg was debrided twice and grew Geotrichum on each 
occasion. A literature search found some relevant 
papers. A 12-year survey of unusual fungal infections at 
M D Anderson cancer center reported 2 patients with 
Geotrichum infections. Neither patient survived. A lo- 
year survey at a tertiary hospital in Bergamo, Italy 
identified 3 cases of Geotrichum with no survivors. 
One antifungal sensitivity study reported MIC’s for 
amphotericin B of 0.39 at 50% and 0.78 at 90% while 
another study reported voriconazole MIC’s of 0.20 at 
50% and 0.39 at 90%. Our patient’s initial antifungal 
therapy of Abelcet and itraconazole was changed to 
Abelcet, caspofungin and voriconazole and was later 
modified to AmBisome, caspofungin, voriconazole and 
flucy-tosine. Neutrophil production was stimulated with 
G-CSF and then, based on a published 3 patient case 
series report, with GM-CSF. Blood cultures have 
become sterile, but the patient has shown little clinical 
progress. The Geotrichum isolate has been forwarded to 
research labs for further testing against comprehensive 
panels of antifungals including the emerging azoles. Our 
patient resolutely continues to re-quest aggressive treat- 
ment for this unusual pathogen. The result of this novel 
therapy against his dire infection remains in question. 
Outcome in central nervous system aspergillosis is 
improved by clinical suspicion and rapid employment 
of imaging, surgery and therapy 
L. Wolfi P Lewis, G. Thomas, i? Moore 
Department of Pediatrics, Oregon Health and Science 
University, Portland, OR, USA 
The fatality rate associated with central nervous system 
(CNS) aspergillosis (Asp) in immunocompromised 
patients is high and often established by autopsy. We 
report 2 patients who were rapidly diagnosed and 
treated for CNS Asp and are longtime survivors. Patient 
1, a 19-year-old male, was diagnosed as having bone 
marrow failure 2 years prior to Ewing’s sarcoma, at 
humerus. He had received TBI. chemotherapy, ATG 
prior to cord blood transplant. Acute mental status 
changes led to an MRl showing multiple ring enhancing 
lesions (MREL). Brain diagnosis (dx) showed A. fumi- 
gatus.The patient received prolonged amphotericin B & 
5-FC and GMCSF. He is now 40 months from CNS Asp. 
Imaging, neuro exam, and bone marrow are normal. He 
attends vocational school. Patient 2, an H-year-old male 
with acute lymphoblastic leukemia had 4 weeks of 
induction therapy when fever and cough led to a CT 
scan (chest) showing multiple lung nodules. CT scan 
brain showed MREL. Open lung biopsy and craniotomy 
with drainage showed Asp, all tissues. He received 
prolonged amphotericin B lipid complex, 5-FC and 
modified ALL therapy. Thirty months after dx Asp, 
imaging and neuro exam are normal; his ALL is in 
remission. He attends high school. With high clinical 
suspicion, rapid use of imaging - expeditious employ- 
ment of surgery, prolonged administration of antifungals 
and maintaining adequate phagocyte counts, the out- 
come of CNS Asp can be improved. 
